MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies

Leukemia

Volumn 14, Issue 3, 2000, Pages 449-456

  Tsuboi, K ^a   Iida, S ^a   Inagaki, H ^a   Kato, M ^a   Hayami, Y ^a   Hanamura, I ^a   Miura, K ^a   Harada, S ^a   Kikuchi, M ^a   Komatsu, H ^a   Banno, S ^a   Wakita, A ^a   Nakamura, S ^b   Eimoto, T ^a   Ueda, R ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Lymphocyte activation; Lymphoma; MUM1 IRF4

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; CELL PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MUM1 PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTE; LYMPHOCYTOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MYELOMA; NONHODGKIN LYMPHOMA; ONCOGENE; PLASMA CELL; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0034009216     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401696     Document Type: Article

References (25)

1. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226-230.
2. Taniguchi T, Harada H, Lamphier M. Regulation of the interferon system and cell growth by the IRF transcription factors. J Cancer Res Clin Oncol 1995; 121: 516-520.
3. Harada H, Taniguchi T, Tanaka N. The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 1998; 80: 641-650.
4. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, O'Connell E, Hu-Li J, Paul WE, Jankovic D, Sher AF, Coligan JE, Thornton A, Appella E, Yang Y, Ozato K. Expression of IFN regulatory factor family proteins in lymphocytes. J Immunol 1996; 156: 3711-3720.
5. Matsuyama T, Grossman A, Mittrücker H-W, Siderovski DP, Kiefer F, Kawakami T, Richardson CD, Taniguchi T, Yoshinaga SK, Mak TW. Molecular cloning of LSIRF, a lymphoid-specific member of the Interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res 1995; 23: 2127-2136.
6. Yamagata T, Nishida J, Tanaka T, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 1996; 16: 1283-1294.
7. Grossman A, Mittrücker H-W, Nicholl J, Suzuki A, Chung S, Antonio L, Suggs S, Sutherland GR, Siderovski DP, Mak TW. Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25. Genomics 1996; 37: 229-233.
8. Eisenbeis C, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 1995; 9: 1377-1387.
9. Pongubala JMR, Atchison ML. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc Natl Acad Sci USA 1997; 94: 127-132.
10. Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW, Arrowsmith CH. Cooperative interaction between the DNA-binding domains of PU.1 and IRF4. J Mol Biol 1998; 279: 1075-1083.
11. Brass AL, Zhu AQ, Singh H. Assembly requirements of PU.1-Pip (IRF4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J 1999; 18: 977-991.
12. Mittrücker H-W, Matsuyama T, Grossman A, Kündig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997; 275: 540-543.
13. Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S, Kamada N, Ariyosbi Y, Takahashi T, Ueda R. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993; 8: 3085-3092.
14. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfliaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the Internalional Lymphoma Study Group. Blood 1994; 84: 1361-1392.
15. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986; 125: 431-435.
16. Glimcher LH, Singh H. Transcription factors in lymphocyte development-T and B cells get together. Cell 1999; 96: 13-23.
17. Cattoretti G, Chang C-C, Cechova K, Zhang J, Ye B, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R. BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86: 45-53.
18. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
19. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphoma. Blood 1998; 92: 1308-1316.
20. Yoshida S, Nakazawa N, Iida S, Hayami Y, Sato S, Wakita A, Shimizu S, Taniwaki M, Ueda R. Detection of MUM1/IRF4-IgH fusion in multiple myeloma. Leukemia 1999; 13: 1812-1816.
21. Efremov DG, Ivanovski M, Batista FD, Pozzato G, Burrone OR. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J Clin Invest 1996; 98: 290-298.
22. Matolcsy A, Casali P, Nador RG, Liu YF, Knowles DM. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells. Blood 1997; 89: 1732-1739.
23. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
24. Naylor M, Carpa JD. Mutational status of IgV, genes provides clinically valuable information in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 1837-1839.
25. Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, Ricciardi-Castagnoli P, Rosen CA, Carter KC. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999; 94: 411-416.